DeepCT vs Rapid ASPECTS
AI Verdict
Choose DeepCT if…
Choose DeepCT if your emergency department requires a comprehensive AI solution for the rapid detection and triage of a broad spectrum of acute brain abnormalities, including intracranial hemorrhage, acute stroke, traumatic brain injury, and fractures. This tool is ideal for improving overall emergency workflow by prioritizing time-sensitive cases and providing early notifications for diverse critical findings.
View DeepCT →Choose Rapid ASPECTS if…
Choose Rapid ASPECTS if your stroke center needs a specialized AI tool to automate and standardize the ASPECTS score from non-contrast CT scans, specifically to quantify early ischemic changes in acute stroke patients. This solution is crucial for quickly and accurately determining thrombectomy eligibility, enhancing diagnostic accuracy, and reducing variability in stroke assessment.
View Rapid ASPECTS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepCT | Rapid ASPECTS |
|---|---|---|
| Pricing | Contact for details | Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states. |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone web-based | Software as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based). |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid ASPECTSRapid ASPECTS offers multiple delivery channels including PACS, email, and mobile/web applications, with a stated fast results delivery under 2 minutes. Its design focuses on reducing cognitive burden and improving reader agreement, directly enhancing the user experience. DeepCT provides flexible deployment options but lacks specific details on user experience or quantified speed of results.
Clinical Value
Rapid ASPECTSWhile DeepCT offers a broader range of detections for various brain abnormalities, Rapid ASPECTS demonstrates superior clinical value through its specialized focus on stroke. It explicitly claims to improve clinician diagnostic accuracy by 10% and increase reader reliability, with its use in landmark clinical trials (DAWN and DEFUSE 3) directly influencing updated stroke treatment guidelines. This strong, validated impact on a critical clinical area gives it an edge.
Pricing & Value
Rapid ASPECTSRapid ASPECTS provides a transparent pricing model, detailing an annual subscription with a starting price of approximately $12,000 for a single module in the US. This transparency allows potential customers to better assess the value proposition. DeepCT, in contrast, does not disclose any public pricing information, making it difficult to evaluate its cost-effectiveness.
Enterprise Readiness
Rapid ASPECTSRapid ASPECTS, through RapidAI, explicitly states 'Yes' for both BAA and HIPAA compliance, which are crucial for enterprise adoption. RapidAI also provides extensive details on its enterprise platform's security, scalability, and seamless integration with PACS, RIS, and EMR systems. DeepCT's compliance claims are less definitive ('Likely'), which could pose a hurdle for large-scale deployments.
Innovation
TieDeepCT showcases innovation through its comprehensive detection capabilities for a broad spectrum of brain abnormalities, including ICH, stroke, TBI, fractures, and midline shift, along with worklist prioritization from a single CT scan. Rapid ASPECTS is highly innovative in its specialized approach to automated, standardized ASPECTS scoring, being the first FDA-cleared CADx neuroimaging solution shown to improve diagnostic accuracy and reader reliability for stroke. Both tools represent significant advancements in healthcare AI.
Support & Docs
Rapid ASPECTSRapid ASPECTS, via its parent company RapidAI, offers extensive customer support, dedicated educational resources through 'Rapid U,' and a comprehensive 'Content Hub' with whitepapers, publications, webinars, and podcasts. DeepCT does not provide any explicit information regarding its customer support or documentation, making Rapid ASPECTS the clear winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepCT | Rapid ASPECTS |
|---|---|---|
| Name | DeepCT | Rapid ASPECTS |
| Company | Deep01 Limited | RapidAI |
| Description | FDA-cleared AI software for the rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities from non-contrast CT scans, aiming to improve emergency workflow and patient outcomes. | Provides an automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. |
| Key Detections/Scores | Intracranial hemorrhage (ICH), midline shift, acute stroke, traumatic brain injury (TBI), fractures, ICH volume, ICH subtype, ICH region, ICH score, Marshall Score, LVO, Ischemic Stroke, Aspect Score, Pneumocephalus. | Automated, standardized ASPECTS score for non-contrast CT scans, visualization of regions of asymmetry and ischemic change. |
| Primary Use Case | Rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities. | Quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. |
Videos
Demos, reviews, and walkthroughs featuring DeepCT and Rapid ASPECTS.